百龙创园(605016) - 2025 Q3 - 季度业绩

Key Financial Data and Indicators for Q3 2025 This section presents a comprehensive overview of the company's key financial performance and position for the third quarter of 2025 Key Financial Data and Indicators for Q3 2025 (Unit: RMB 10,000) | Item | Current Period | Prior Year Period | Change (%) | | :--- | :--- | :--- | :--- | | Income Statement Data (Q3 2025 vs Q3 2024): | | | | | Total Operating Revenue | 96,889.56 | 82,038.74 | 18.10 | | Operating Profit | 31,209.45 | 20,841.02 | 49.75 | | Total Profit | 31,198.12 | 20,814.07 | 49.89 | | Net Profit Attributable to Shareholders of the Listed Company | 26,462.57 | 18,259.16 | 44.93 | | Net Profit Attributable to Shareholders of the Listed Company (Excluding Non-Recurring Gains and Losses) | 26,007.56 | 17,291.11 | 50.41 | | Basic Earnings Per Share (RMB) | 0.63 | 0.57 | 10.53 | | Weighted Average Return on Net Assets (%) | 14.61 | 11.42 | Increased by 3.19 percentage points | | Balance Sheet Data (Q3 2025 End vs Q4 2024 Beginning): | | | | | Total Assets | 257,782.62 | 201,350.48 | 28.03 | | Owners' Equity Attributable to Shareholders of the Listed Company | 187,763.02 | 167,923.71 | 11.81 | | Share Capital (10,000 shares) | 42,001.23 | 32,308.64 | 30.00 | | Net Assets Per Share Attributable to Shareholders of the Listed Company (RMB) | 4.47 | 5.02 | -13.99 | Explanation of Operating Performance and Financial Condition This section provides a detailed explanation of the company's operational achievements and financial health during the reporting period Operating Performance The company achieved steady revenue growth and rapid profit increase in Q3 2025, driven by product structure optimization, new capacity release, and share capital expansion - In Q3 2025, the company's total operating revenue reached RMB 96,889.56 10,000, an 18.10% year-over-year increase; net profit attributable to shareholders was RMB 26,462.57 10,000, up 44.93%; basic earnings per share was RMB 0.63, an increase of 10.53%[4] - Performance growth was primarily due to product structure optimization and increased sales and revenue from the release of capacity from the "Annual Production of 30,000 Tons of Soluble Dietary Fiber Project" and "Annual Production of 15,000 Tons of Crystalline Sugar Project"[4] - The increase in basic earnings per share was lower than net profit growth, mainly because the company's 2024 equity distribution involved a capital reserve transfer of 3 shares for every 10 shares to all shareholders, increasing total share capital by 30.00% to 42,001.23 10,000 shares[3][4] Financial Condition As of the end of the reporting period, the company's financial condition remained stable, with increases in total assets and owners' equity, though per-share net assets decreased due to a significant increase in share capital from capital reserve transfers - As of the end of the reporting period, the company's total assets were RMB 257,782.62 10,000, an increase of 28.03% from the beginning of the period; owners' equity attributable to shareholders was RMB 187,763.02 10,000, an increase of 11.81% from the beginning of the period[5] - The company's share capital increased to 42,001.23 10,000 shares, a 30.00% increase from the beginning of the period, primarily due to the 2024 annual equity distribution involving a capital reserve transfer of 3 shares for every 10 shares to all shareholders[3][5] - Net assets per share attributable to shareholders was RMB 4.47, a 13.99% decrease from the beginning of the period, also primarily due to the increase in total share capital[3][5] Risk Warning This section highlights the preliminary nature of the financial data and advises investors to exercise caution - The key financial data for Q3 2025 contained in this announcement are preliminary and unaudited by an accounting firm; investors are advised to note investment risks, as specific data will be subject to the company's official Q3 2025 report[1][6] Documents for Reference This section lists the comparative balance sheet and income statement as supporting documents - Documents for reference include the comparative balance sheet and income statement, signed and sealed by the company's principal, the person in charge of accounting, and the head of the accounting department[7]